Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 0 | 109 | 59 | 0 |
| Cost of Goods | N/A | N/A | 69 | 54 | N/A |
| Gross Profit | N/A | N/A | 40 | 5 | N/A |
| Operating Expenses | 3,115 | 3,576 | 7,015 | 8,353 | 7,418 |
| Operating Income | -3,115 | -3,576 | -6,906 | -8,294 | -7,418 |
| Interest Expense | 83 | 95 | 1 | 4 | 6 |
| Other Income | -500 | -1,835 | 0 | 71 | 294 |
| Pre-tax Income | -3,698 | -5,506 | -6,907 | -8,227 | -7,129 |
| Net Income Continuous | -3,698 | -5,506 | -6,907 | -8,227 | -7,129 |
| Net Income Discontinuous | N/A | N/A | -2,008 | -96 | N/A |
| Net Income | $-3,698 | $-5,506 | $-8,914 | $-8,323 | $-7,129 |
| EPS Basic Total Ops | -0.34 | -0.50 | -1.33 | -1.41 | -1.60 |
| EPS Basic Continuous Ops | -0.29 | -0.50 | -1.04 | -1.39 | -1.68 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.29 | -0.02 | N/A |
| EPS Diluted Total Ops | -0.34 | -0.50 | -1.33 | -1.41 | -1.60 |
| EPS Diluted Continuous Ops | -0.29 | -0.50 | -1.04 | -1.39 | -1.68 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.29 | -0.02 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.34 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,105 | $-3,563 | $-6,610 | $-8,013 | $-7,223 |